Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients.

Elger T, Loibl J, Müller M, Rusch S, Baier-Kleinhenz L, Kandulski A, Buechler C, Tews HC

Open source

DOI
10.3390/biomedicines14092117
Published
2026 Sep 19
Container
Biomedicines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14092117,
  title = {Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients.},
  author = {Elger T and Loibl J and Müller M and Rusch S and Baier-Kleinhenz L and Kandulski A and Buechler C and Tews HC},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14092117},
  url = {https://doi.org/10.3390/biomedicines14092117}
}

RIS

TY  - JOUR
TI  - Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients.
AU  - Elger T
AU  - Loibl J
AU  - Müller M
AU  - Rusch S
AU  - Baier-Kleinhenz L
AU  - Kandulski A
AU  - Buechler C
AU  - Tews HC
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14092117
UR  - https://doi.org/10.3390/biomedicines14092117
ER  - 

APA

T, E., J, L., M, M., S, R., L, B., A, K., C, B., & HC, T. (2026). Safety of Biologic Therapy for Inflammatory Bowel Disease in Liver Transplant Recipients.. Biomedicines. https://doi.org/10.3390/biomedicines14092117

Source records